MEGAN PARSONS: Open Payments
NPI 1316652506 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,933 in 84 payments from 14 companies in 2025. Trend: 2023 $829 · 2024 $1,386 · 2025 $1,933
Food & beverage: $1,655Education: $278
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $381 |
| Janssen Biotech, Inc. | 13 | $368 |
| Organogenesis Inc. | 9 | $207 |
| GENZYME CORPORATION | 5 | $150 |
| UCB, Inc. | 9 | $146 |
| LEO Pharma Inc. | 8 | $140 |
| Regeneron Healthcare Solutions, Inc. | 2 | $125 |
| Novartis Pharmaceuticals Corporation | 7 | $124 |
| Lilly USA, LLC | 7 | $115 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $53 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, Bimzelx, ADBRY, TALTZ, Rhapsido.
Industry payments across MO — which companies pay providers there.
